Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control

NCT03338153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1353

Last updated 2017-11-09

No results posted yet for this study

Summary

the purpose of this study is to determine whether appropriate control of diabetes around the PCI time is related with MACE and outcome of diabetic patients.

Conditions

Sponsors & Collaborators

  • Tehran Heart Center

    lead OTHER

Principal Investigators

  • Ebrahim kassaian, MD · Tehran Heart Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-12-31
Completion
2013-03-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338153 on ClinicalTrials.gov